Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.18 USD | +0.49% |
|
-3.33% | -15.49% |
May. 07 | DA Davidson Adjusts Price Target on USANA Health Sciences to $46 From $48, Maintains Neutral Rating | MT |
May. 01 | Transcript : USANA Health Sciences, Inc., Q1 2024 Earnings Call, May 01, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.49% | 857M | |
+12.68% | 7.89B | |
-0.41% | 7.2B | |
-4.02% | 5.75B | |
-8.14% | 3.64B | |
-15.09% | 3.42B | |
-15.25% | 1.16B | |
-27.33% | 1.1B | |
+6.69% | 906M | |
-11.94% | 828M |
- Stock Market
- Equities
- USNA Stock
- News USANA Health Sciences, Inc.
- USANA Health Sciences : Roth Capital Adjusts Price Target on USANA Health Sciences to $126 From $107, Maintains Buy Rating